BioHax WellnessBioHax Wellness Facebook ad: “Wegovy Tablet In Australia: Cost, Safety, Side Effects…”
Ran for 66 days, from January 8 to March 15, 2026, the last day Crush saw it.
Run by BioHax Wellness on Facebook. Crush is not the advertiser and does not verify its claims. See this ad in Meta's Ad Library(opens in a new tab)
Want an ad like this for your product?
Crush makes new ad images for your product from this ad: your logo, your product photo, your offer.
Trials from $19.95 USD, then $79.95 USD a month. Cancel anytime.
About this ad
- Meta Ad Library ID
- 1651027922936960
- Platforms
- Facebook, Instagram, Audience Network and Messenger
- Relaunches
- 0
Ad text
Wegovy didn’t just change weight loss. It changed the rules. And now semaglutide comes in tablet form… a legitimate medical tool for people living with obesity and metabolic chaos. Appetite drops. Blood sugar steadies. Heart risk falls. This is real medicine, not a trend. But tools need boundaries. Side-effects happen. Weight can rebound when you stop. And if you’re not obese but chasing vanity results; you’re playing with your muscle mass, not just your appetite. Right patient, right prescription, right support. That’s the whole story. 👉 If you’re on Instagram click the link in bio or go to our website: BioHax Brief Menu < Breaking News 👇If you’re on Facebook, the link is in the comments below. All the big shifts, updated weekly inside BioHax Brief and Breaking Wellness News. Save it. Share it. Stay informed. #biohaxwellness #breakingwellnessnews #wegovy #semaglutide #metabolichealth
Where the ad sends people
biohax.com.au
Wegovy Tablet In Australia: Cost, Safety, Side Effects, Access
The new Wegovy weight-loss tablet is approved in the U.S. but not yet in Australia. Here’s the price, safety risks, side effects and who it’s really for.
Learn more: biohax.com.au(opens in a new tab)
